Calamos Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Hold |
45,753
| – | – | 0.08% | 256 |
|
|
2025
Q1 | $22.2M | Buy |
45,753
+509
| +1% | +$247K | 0.1% | 225 |
|
|
2024
Q4 | $18.2M | Hold |
45,244
| – | – | 0.08% | 265 |
|
|
2024
Q3 | $21M | Sell |
45,244
-1,189
| -3% | -$553K | 0.09% | 251 |
|
|
2024
Q2 | $21.8M | Sell |
46,433
-1,691
| -4% | -$793K | 0.1% | 230 |
|
|
2024
Q1 | $20.1M | Sell |
48,124
-21,048
| -30% | -$8.8M | 0.1% | 245 |
|
|
2023
Q4 | $28.1M | Sell |
69,172
-923
| -1% | -$376K | 0.14% | 189 |
|
|
2023
Q3 | $24.4M | Hold |
70,095
| – | – | 0.13% | 198 |
|
|
2023
Q2 | $24.7M | Sell |
70,095
-11,477
| -14% | -$4.04M | 0.12% | 208 |
|
|
2023
Q1 | $25.7M | Sell |
81,572
-10,185
| -11% | -$3.21M | 0.13% | 199 |
|
|
2022
Q4 | $26.5M | Sell |
91,757
-16,171
| -15% | -$4.67M | 0.12% | 204 |
|
|
2022
Q3 | $31.2M | Buy |
107,928
+37
| +0% | +$10.7K | 0.14% | 170 |
|
|
2022
Q2 | $30.4M | Buy |
107,891
+2,904
| +3% | +$818K | 0.13% | 181 |
|
|
2022
Q1 | $27.4M | Buy |
104,987
+13,837
| +15% | +$3.61M | 0.1% | 223 |
|
|
2021
Q4 | $20M | Sell |
91,150
-19,807
| -18% | -$4.35M | 0.07% | 262 |
|
|
2021
Q3 | $20.1M | Sell |
110,957
-17,046
| -13% | -$3.09M | 0.09% | 238 |
|
|
2021
Q2 | $25.8M | Sell |
128,003
-71,266
| -36% | -$14.4M | 0.12% | 190 |
|
|
2021
Q1 | $42.8M | Buy |
199,269
+57,190
| +40% | +$12.3M | 0.23% | 96 |
|
|
2020
Q4 | $33.6M | Sell |
142,079
-4,076
| -3% | -$963K | 0.19% | 128 |
|
|
2020
Q3 | $39.8M | Sell |
146,155
-25,789
| -15% | -$7.02M | 0.26% | 96 |
|
|
2020
Q2 | $49.9M | Buy |
171,944
+57,288
| +50% | +$16.6M | 0.35% | 62 |
|
|
2020
Q1 | $27.3M | Buy |
114,656
+72,931
| +175% | +$17.4M | 0.21% | 140 |
|
|
2019
Q4 | $9.14M | Sell |
41,725
-727
| -2% | -$159K | 0.05% | 349 |
|
|
2019
Q3 | $7.19M | Buy |
42,452
+3,681
| +9% | +$624K | 0.04% | 401 |
|
|
2019
Q2 | $7.11M | Buy |
38,771
+1,928
| +5% | +$354K | 0.04% | 399 |
|
|
2019
Q1 | $6.78M | Buy |
36,843
+408
| +1% | +$75K | 0.04% | 367 |
|
|
2018
Q4 | $6.04M | Buy |
36,435
+5,455
| +18% | +$904K | 0.04% | 369 |
|
|
2018
Q3 | $5.97M | Sell |
30,980
-3,148
| -9% | -$607K | 0.03% | 391 |
|
|
2018
Q2 | $5.8M | Buy |
34,128
+4,028
| +13% | +$685K | 0.04% | 371 |
|
|
2018
Q1 | $4.91M | Buy |
30,100
+1,418
| +5% | +$231K | 0.03% | 404 |
|
|
2017
Q4 | $4.3M | Sell |
28,682
-547
| -2% | -$82K | 0.02% | 390 |
|
|
2017
Q3 | $4.44M | Buy |
29,229
+1,022
| +4% | +$155K | 0.03% | 386 |
|
|
2017
Q2 | $3.64M | Buy |
+28,207
| New | +$3.64M | 0.03% | 415 |
|
|
2014
Q1 | – | Sell |
-43,138
| Closed | -$3.21M | – | 644 |
|
|
2013
Q4 | $3.21M | Buy |
+43,138
| New | +$3.21M | 0.02% | 361 |
|